Cargando…
Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis
Glial cell activation precedes neuronal cell death during brain aging and the progression of neurodegenerative diseases. Under neuroinflammatory stress conditions, lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin or 24p3, is produced and secreted by activated microglia an...
Autores principales: | Jung, Byung-Kwon, Ryu, Kwon-Yul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618504/ https://www.ncbi.nlm.nih.gov/pubmed/37779143 http://dx.doi.org/10.1038/s12276-023-01098-7 |
Ejemplares similares
-
Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021) -
Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders
por: Morris, Gerwyn, et al.
Publicado: (2020) -
[(18)F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
por: Ballweg, Anna, et al.
Publicado: (2023) -
Mild Oxidative Stress Induced by Sodium Arsenite Reduces Lipocalin-2 Expression Levels in Cortical Glial Cells
por: Cho, Ye-Jin, et al.
Publicado: (2023) -
Imaging of Reactive Astrogliosis by Positron Emission Tomography
por: Harada, Ryuichi, et al.
Publicado: (2022)